Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samir Parekh

Showing results (121-130 of 162) with videos related to

Pageof 17
Sort By:
Blood|April 30, 2010
Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphomaVioletta V Leshchenko, Pei-Yu Kuo, Rita Shaknovich, et al.
Blood Advances|August 26, 2022
Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myelomaTarek H Mouhieddine, Oliver Van Oekelen, David T Melnekoff, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Spatial multi-omics of multiple myeloma uncovers niche-dependent pro-myeloma and immunosuppressive signaling in the bone marrow and extramedullary lesionsDenis J Ohlstrom, Marina E Michaud, Mojtaba Bakhtiari, et al.
Blood Advances|September 29, 2023
Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groupsUrvi A Shah, Erin Moshier, Andriy Derkach, et al.
Blood|June 23, 2012
Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDSLaura Barreyro, Britta Will, Boris Bartholdy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2013
Myeloma is characterized by stage-specific alterations in DNA methylation that occur early during myelomagenesisChristoph J Heuck, Jayesh Mehta, Tushar Bhagat, et al.
JCI Insight|May 5, 2026
Detection of cytokine release syndrome using wearables and cytokine profiling following CAR-T therapy for myelomaSridevi Rajeeve, Matt Wilkes, Nicole Zahradka, et al.
Communications Biology|January 7, 2023
Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurementsRobert J Kimmerling, Mark M Stevens, Selim Olcum, et al.
Blood Cancer Discovery|September 16, 2024
Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair GenesSantiago Thibaud, Ryan L Subaran, Scott Newman, et al.
JCO Precision Oncology|January 18, 2024
Cellular Mass Response to Therapy Correlates With Clinical Response for a Range of MalignanciesMark M Stevens, Robert J Kimmerling, Selim Olcum, et al.
Pageof 17

Showing results (121-130 of 162) with videos related to

Sort By:
Pageof 17
Blood|April 30, 2010
Genomewide DNA methylation analysis reveals novel targets for drug development in mantle cell lymphomaVioletta V Leshchenko, Pei-Yu Kuo, Rita Shaknovich, et al.
Blood Advances|August 26, 2022
Sequencing T-cell redirection therapies leads to deep and durable responses in patients with relapsed/refractory myelomaTarek H Mouhieddine, Oliver Van Oekelen, David T Melnekoff, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Spatial multi-omics of multiple myeloma uncovers niche-dependent pro-myeloma and immunosuppressive signaling in the bone marrow and extramedullary lesionsDenis J Ohlstrom, Marina E Michaud, Mojtaba Bakhtiari, et al.
Blood Advances|September 29, 2023
Prevalence and impact of diabetes on survival of patients with multiple myeloma in different racial groupsUrvi A Shah, Erin Moshier, Andriy Derkach, et al.
Blood|June 23, 2012
Overexpression of IL-1 receptor accessory protein in stem and progenitor cells and outcome correlation in AML and MDSLaura Barreyro, Britta Will, Boris Bartholdy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 15, 2013
Myeloma is characterized by stage-specific alterations in DNA methylation that occur early during myelomagenesisChristoph J Heuck, Jayesh Mehta, Tushar Bhagat, et al.
JCI Insight|May 5, 2026
Detection of cytokine release syndrome using wearables and cytokine profiling following CAR-T therapy for myelomaSridevi Rajeeve, Matt Wilkes, Nicole Zahradka, et al.
Communications Biology|January 7, 2023
Publisher Correction: A pipeline for malignancy and therapy agnostic assessment of cancer drug response using cell mass measurementsRobert J Kimmerling, Mark M Stevens, Selim Olcum, et al.
Blood Cancer Discovery|September 16, 2024
Multiple Myeloma Risk and Outcomes Are Associated with Pathogenic Germline Variants in DNA Repair GenesSantiago Thibaud, Ryan L Subaran, Scott Newman, et al.
JCO Precision Oncology|January 18, 2024
Cellular Mass Response to Therapy Correlates With Clinical Response for a Range of MalignanciesMark M Stevens, Robert J Kimmerling, Selim Olcum, et al.
Pageof 17